• Glass House Brands filed applications to register certain California-licensed medical cannabis operations with U.S. Drug Enforcement Administration under expedited pathway tied to medical cannabis rescheduling to Schedule III.
• DEA process allows eligible state-licensed medical dispensaries to operate under Schedule III during a 60-day window while applications are reviewed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glass House Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605060730PRIMZONECNPR____9713760) on May 06, 2026, and is solely responsible for the information contained therein.